mRNA Vaccine Development Mistake

Larry A. Law

A team of international scientists obtained Pfizer's biodistribution study from a Japanese regulatory agency. Canadian immunologist and vaccine researcher, Byram Bridle, Ph.D., said that vaccine developers at Pfizer assumed the mRNA in the vaccines would remain in and around the vaccine injection site. However, the data Pfizer reported show that while the majority of mRNA initially remains near the deltoid muscle injection site, within hours it becomes widely distributed throughout the body producing spike protein in unintended organs and tissues including the circulatory and reproductive systems.

"We made a big mistake," Bridle says. "We thought the spike protein was a great target antigen; we never knew the spike protein itself was a toxin and was a pathogenic protein. So, by vaccinating people we are inadvertently inoculating them with a toxin."

The study shows that Pfizer omitted industry-standard studies on reproductive toxicity and genotoxicity (DNA mutation). In addition, Pfizer did not even use the commercial vaccine (BNT162b2) in key studies but instead relied on a surrogate mRNA producing the luciferase protein. Since the actual vaccine was never tested, it is no surprise that significant problems are showing up. Women have reported changes in menstruation after taking mRNA vaccines and miscarriages have been reported through the Vaccine Adverse Events Reporting System (VAERS). The mRNA enters the bloodstream and accumulates in organs like the spleen, liver, adrenal glands, ovaries, and bone marrow. It travels to the heart, brain, and lungs and can be expelled in breast milk which could be lethal to a baby. 

Problems with blood clotting are very serious. The spike protein on its own is entirely responsible for the damage to the cardiovascular system. Pfizer's assumption that the spike protein would not enter the circulatory system was a "grave mistake." It can remain in the bloodstream for 29 days. It binds to platelet receptors and the epithelial cells lining blood vessels. The immune system identifies something foreign in the lining and starts to attack it causing inflammation. Platelets clump together in response to the blood vessel damage. A reduction in platelet count (thrombocytopenia) is a sure sign that blood clots are forming and are being used up in the process. This increases the risk of death more than 50 times. People who have been vaccinated against COVID-19 should absolutely not donate blood because the vaccine and spike protein are both transferred. The damage to fragile patients could be lethal.

The glycocalyx is the protective layer of glycoproteins on all cells. It is the cell membrane. The glycocalyx on surface cells inside the blood vessel represent our most powerful anticlotting system. They contain a wide variety of anticoagulant factors including tissue factor inhibitor, protein C, nitric oxide and antithrombin. The glycocalyx modulates the adhesion of platelets to the endothelium (the inner lining of blood vessels and the heart). When blood clots completely block a blood vessel, a stroke or heart attack results. While the spike protein found on the virus is bad, the spike protein produced by our body in response to the mRNA vaccine is far worse. The mRNA vaccine programs the cell to produce a synthetic, genetically engineered spike protein. Specific alterations make it far more toxic than the one found on the virus. Normally the spike protein on the virus will collapse on itself and fall into the cell once it attaches to the ACE2 receptor on the cell. The vaccine-induced spike protein does not. It stays open and remains attached to the ACE2 receptor, disabling it and causing a host of problems leading to heart, lung, and immune system impairment.

For more information on concerns with vaccinations and how glycobiology relates to the human body, see my book.​